[go: up one dir, main page]

WO2007130581A3 - Compositions et procédés pour traiter les troubles psychiatriques et stimuler les processus cognitifs - Google Patents

Compositions et procédés pour traiter les troubles psychiatriques et stimuler les processus cognitifs Download PDF

Info

Publication number
WO2007130581A3
WO2007130581A3 PCT/US2007/010851 US2007010851W WO2007130581A3 WO 2007130581 A3 WO2007130581 A3 WO 2007130581A3 US 2007010851 W US2007010851 W US 2007010851W WO 2007130581 A3 WO2007130581 A3 WO 2007130581A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
psychiatric conditions
cognition enhancement
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/010851
Other languages
English (en)
Other versions
WO2007130581A2 (fr
Inventor
Susan B Hardwicke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2007130581A2 publication Critical patent/WO2007130581A2/fr
Anticipated expiration legal-status Critical
Publication of WO2007130581A3 publication Critical patent/WO2007130581A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions et des procédés servant à la prévention, à l'amélioration, au traitement et/ou à la guérison de troubles psychiatriques, notamment du trouble déficitaire de l'attention avec hyperactivité et du trouble déficitaire de l'attention, ainsi que des compositions et des procédés servant à stimuler les processus cognitifs. Les compositions selon l'invention, une composition nutraceutique ou une composition pharmaceutique par exemple, peuvent comprendre de l'ARN et, éventuellement, un agent acétylcholine, de la gelée royale et un support de qualité nutraceutique ou pharmaceutique.
PCT/US2007/010851 2006-05-04 2007-05-04 Compositions et procédés pour traiter les troubles psychiatriques et stimuler les processus cognitifs Ceased WO2007130581A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79747706P 2006-05-04 2006-05-04
US60/797,477 2006-05-04

Publications (2)

Publication Number Publication Date
WO2007130581A2 WO2007130581A2 (fr) 2007-11-15
WO2007130581A3 true WO2007130581A3 (fr) 2008-12-18

Family

ID=38668335

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/010851 Ceased WO2007130581A2 (fr) 2006-05-04 2007-05-04 Compositions et procédés pour traiter les troubles psychiatriques et stimuler les processus cognitifs

Country Status (1)

Country Link
WO (1) WO2007130581A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106470547B (zh) * 2014-05-08 2020-10-09 帝斯曼知识产权资产管理有限公司 包含10-羟基-2-癸烯酸的方法和组合物
KR102496390B1 (ko) 2014-06-06 2023-02-03 디킨 유니버시티 신경발달 질환 및 장애의 치료 방법
TWI793922B (zh) * 2021-12-14 2023-02-21 彥臣生技藥品股份有限公司 一種用於提升認知能力之組合物及其用途

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BURGESS ET AL.: "Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder", AM. J. CLIN. NUTR., vol. 71, no. 1, SUPPL., January 2000 (2000-01-01), pages 327S - 330S, XP008000462 *
SACCO ET AL.: "Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders", J. PSYCHOPHARMACOL., vol. 18, no. 4, December 2004 (2004-12-01), pages 457 - 474 *

Also Published As

Publication number Publication date
WO2007130581A2 (fr) 2007-11-15

Similar Documents

Publication Publication Date Title
WO2008064351A3 (fr) (r)-n-stéréoisomères d'analogues 4,5-époxy-morphinanium saturé en position 7 et 8
WO2007011962A3 (fr) Traitement du cancer
WO2008013589A3 (fr) Traitement de tumeurs exprimant ras
WO2006107451A3 (fr) Derives d'honokiol pour traiter les maladies proliferantes
WO2008022295A3 (fr) anticorps spécifiques du PRLR et leurs utilisations
WO2008030883A3 (fr) Traitement du cancer
WO2007092622A3 (fr) Compositions et méthodes pour le traitement d'os
WO2008021368A3 (fr) Compositions et méthodes de neuroprotection
WO2007111864A3 (fr) Composes antagonistes du recepteur du glucagon, compositions contenant de tels composes et procedes d'utilisation
WO2007109279A3 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
WO2006037024A3 (fr) Sels de decitabine
WO2007146965A3 (fr) Composés destinés au traitement d'une maladie périodontale
WO2007136577A3 (fr) Composés antagonistes du récepteur du glucagon, compositions contenant ces composés, et procédés d'utilisation
WO2007059007A3 (fr) Marqueurs d'endoderme definitif
WO2007064872A3 (fr) Composes de l'uree utilises dans le traitement du cancer
WO2006034154A3 (fr) Sels de 5-azacytidine
WO2006104945A3 (fr) Therapies contre l'hepatite c
WO2007100777A3 (fr) Méthodes pour le traitement du tdah et de troubles apparentés
WO2007146335A3 (fr) Composés et compositions pour le traitement du cancer
WO2007059008A3 (fr) Indenoisoquinolines n-substituees et leur synthese
WO2008019326A3 (fr) Anticorps spécifique de ephb3 et ses utilisations
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2007111982A3 (fr) Méthodes de traitement de troubles cognitifs et autres
WO2007098047A3 (fr) Procédé et compositions pour le traitement de la maladie de parkinson
WO2006121684A3 (fr) Methodes d'utilisation d'acylhydrazones comme inhibiteurs de seh

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07756211

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07756211

Country of ref document: EP

Kind code of ref document: A2